Cambridge, MA, United States of America

Robert Meissner


 

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Newton Center, MA (US) (2020)
  • Cambridge, MA (US) (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Robert Meissner: Innovator in IRAK4 Inhibiting Agents

Introduction

Robert Meissner, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of three patents, Meissner focuses on developing innovative treatments for various diseases through the use of IRAK4 inhibiting agents.

Latest Patents

Robert Meissner's latest patents include groundbreaking compounds designed to inhibit IRAK-4, a vital target in treating inflammatory and autoimmune diseases, as well as cancers and other conditions. These patents provide formulations of compounds, including pharmaceutically acceptable salts, along with their production methods. The applications of these compounds extend to treating a variety of diseases such as cardiovascular issues, central nervous system disorders, skin conditions, ophthalmic diseases, and bone ailments.

Career Highlights

Currently affiliated with Biogen MA Inc., Robert Meissner has built a reputation as a leading inventor in his field. His work demonstrates a commitment to advancing medical research and improving patient outcomes through innovative treatment methodologies.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues, including Timothy Raymond Chan and Kevin Guckian. These partnerships have fostered an environment of creativity and innovation, propelling their shared research endeavors to new heights.

Conclusion

In conclusion, Robert Meissner stands out as a pivotal figure in the world of pharmaceutical innovation. Through his patents on IRAK4 inhibiting agents, he is not only contributing to the scientific community but also striving to bring forth new therapies for complex diseases, ultimately making a substantial impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…